开发治疗C3淋巴细胞病变的疗法:脏健康倡议的报告C3淋巴细胞病变试验终点工作组工作组
Carla Nester1, Dima A Decker2, Matthias Meier3
1Department of Pediatrics, Division of Nephrology, Carver College of Medicine, University of Iowa, Iowa City, Iowa.
概括
专家们回顾了C3球囊病 (C3G) 治疗的试验终点. 虽然具体的值仍未确定,但对蛋白尿,eGFR和组织病理学的积极影响被认为是补充途径疗法的强迫因素.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 补充生物学 补充生物学
- 临床试验设计 临床试验设计
背景情况:
- C3球囊病 (C3G) 是一种罕见的球囊病.
- 针对替代补充途径的新药正在对C3G进行临床试验.
- 需要标准化试验终点来评估治疗疗效.
研究的目的:
- 评估支持预规定的试验终点的数据,以评估C3G中的临床益处.
- 确定C3G治疗本土脏的令人信服的疗效研究结果.
- 解决C3G临床试验终点评估中的知识差距.
主要方法:
- 召集了C3G专家小组和试验终点工作组.
- 审查了证据和不确定性,将蛋白尿,eGFR和组织病理与结果联系起来.
- 组讨论和反对终点数据的子组总结.
主要成果:
- 专家们一致同意了支持所选终点的数据和不确定性的表征.
- 由于数据的限制,无法定义终点变化的最低临床上有意义的值.
- 对所有三个终点 (蛋白尿,eGFR,组织病理学) 的有利治疗效果将是有效性的令人信服的证据.
结论:
- 一种治疗可以被认为是有效的,具有显著的蛋白尿减少和稳定/改善的eGFR,即使没有完整的终点对齐.
- 学术界和行业合作伙伴之间的数据共享对于解决知识差距至关重要.
- 需要进一步的研究来确定C3G疗法的最终临床益处值.
相关概念视频
01:27Open Angle Glaucoma: Treatment
427
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
427
01:28Angle Closure Glaucoma: Treatment
473
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
473